Heparanase is considered a critical molecular determinant of brain metastasis [114] in melanoma [115] and breast cancer [116], but surprisingly high exogenous heparanase concentrations were shown to downregulate invasion of brain metastatic melanoma cells [117]. Here, HPSE is linked to breast carcinoma.